GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inner Mongolia Grand Pharmaceutical Co Ltd (BJSE:836433) » Definitions » Price-to-Operating-Cash-Flow

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Price-to-Operating-Cash-Flow : 289.29 (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inner Mongolia Grand Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Inner Mongolia Grand Pharmaceutical Co's share price is ¥4.05. Inner Mongolia Grand Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01. Hence, Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 289.29.

The historical rank and industry rank for Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

BJSE:836433' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.39   Med: 21.82   Max: 372.22
Current: 289.29

During the past 11 years, Inner Mongolia Grand Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 372.22. The lowest was 5.39. And the median was 21.82.

BJSE:836433's Price-to-Operating-Cash-Flow is ranked worse than
98.24% of 682 companies
in the Drug Manufacturers industry
Industry Median: 16.105 vs BJSE:836433: 289.29

Inner Mongolia Grand Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01.

During the past 11 years, Inner Mongolia Grand Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 134.60% per year. The lowest was -45.20% per year. And the median was -21.20% per year.


Inner Mongolia Grand Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Grand Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

Inner Mongolia Grand Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.61 7.78 77.17 10.00 -

Inner Mongolia Grand Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 35.93 178.89 - 370.00

Competitive Comparison of Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Inner Mongolia Grand Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=4.05/0.014
=289.29

Inner Mongolia Grand Pharmaceutical Co's Share Price of today is ¥4.05.
Inner Mongolia Grand Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Inner Mongolia Grand Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Grand Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Business Description

Traded in Other Exchanges
N/A
Address
Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010
Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production and sales of special specialty medicines and general health products. The company's main business is the research and development and production of Chinese patent medicines (including ethnic medicines) and chemical preparations and sales.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Headlines

No Headlines